Zhejiang DiAn Diagnostics Co Total Liabilities
Zhejiang DiAn Diagnostics Co total liabilities. Based on the latest financial reports, Zhejiang DiAn Diagnostics Co (300244) has total liabilities worth CN¥5.41 Billion CNY (≈ $792.25 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 300244 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang DiAn Diagnostics Co (2008–2025)
Total liabilities of Zhejiang DiAn Diagnostics Co from 2008 to 2025. This chart illustrates how Zhejiang DiAn Diagnostics Co's total liabilities have evolved over time, based on quarterly financial data. Explore Zhejiang DiAn Diagnostics Co strategic investment ratio to see how much of total assets are deployed in long-term investments.
Zhejiang DiAn Diagnostics Co Competitors by Total Liabilities
The table below lists competitors of Zhejiang DiAn Diagnostics Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Happen, Inc. Common Stock
NASDAQ:HAPN
|
USA | $10.98 Billion |
|
Alamo Group Inc
NYSE:ALG
|
USA | $462.37 Million |
|
Dime Community Bancshares, Inc.
NYSE:DCOM
|
USA | $13.49 Billion |
|
Parex Resources Inc
TO:PXT
|
Canada | CA$1.88 Billion |
|
Viet Nam International Commercial Joint Stock Bank
VN:VIB
|
Vietnam | ₫533.16 Trillion |
|
Nickel Industries Ltd
AU:NIC
|
Australia | AU$1.54 Billion |
|
Lily Group Co Ltd
SHG:603823
|
China | CN¥820.71 Million |
|
Sonos Inc
NASDAQ:SONO
|
USA | $455.12 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Zhejiang DiAn Diagnostics Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Zhejiang DiAn Diagnostics Co assets under control.
Liquidity & Leverage Metrics
Zhejiang DiAn Diagnostics Co Total Liabilities Ratios Explained
Zhejiang DiAn Diagnostics Co total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.83 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang DiAn Diagnostics Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang DiAn Diagnostics Co (2008–2025)
The table below shows the annual total liabilities of Zhejiang DiAn Diagnostics Co from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥5.82 Billion ≈ $851.37 Million |
-17.11% |
| 2024-12-31 | CN¥7.02 Billion ≈ $1.03 Billion |
-12.64% |
| 2023-12-31 | CN¥8.03 Billion ≈ $1.18 Billion |
-30.46% |
| 2022-12-31 | CN¥11.55 Billion ≈ $1.69 Billion |
+42.32% |
| 2021-12-31 | CN¥8.12 Billion ≈ $1.19 Billion |
+27.44% |
| 2020-12-31 | CN¥6.37 Billion ≈ $932.13 Million |
+13.51% |
| 2019-12-31 | CN¥5.61 Billion ≈ $821.19 Million |
-5.88% |
| 2018-12-31 | CN¥5.96 Billion ≈ $872.50 Million |
+34.20% |
| 2017-12-31 | CN¥4.44 Billion ≈ $650.13 Million |
+40.08% |
| 2016-12-31 | CN¥3.17 Billion ≈ $464.10 Million |
+157.15% |
| 2015-12-31 | CN¥1.23 Billion ≈ $180.48 Million |
+203.14% |
| 2014-12-31 | CN¥406.86 Million ≈ $59.54 Million |
+83.54% |
| 2013-12-31 | CN¥221.68 Million ≈ $32.44 Million |
+23.96% |
| 2012-12-31 | CN¥178.83 Million ≈ $26.17 Million |
+44.61% |
| 2011-12-31 | CN¥123.66 Million ≈ $18.09 Million |
+66.35% |
| 2010-12-31 | CN¥74.33 Million ≈ $10.88 Million |
+8.73% |
| 2009-12-31 | CN¥68.37 Million ≈ $10.00 Million |
-17.59% |
| 2008-12-31 | CN¥82.96 Million ≈ $12.14 Million |
-- |
About Zhejiang DiAn Diagnostics Co
Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated… Read more